
Daniel J. Buysse, MD, is the UPMC Endowed Chair of Sleep Medicine and Professor of Psychiatry and Clinical and Translational Science at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Michigan and completed his residency and fellowship training at the University of Pittsburgh. His res
Daniel J. Buysse, MD, is the UPMC Endowed Chair of Sleep Medicine and Professor of Psychiatry and Clinical and Translational Science at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Michigan and completed his residency and fellowship training at the University of Pittsburgh. His research focuses on the assessment, pathophysiology, and treatment of insomnia; the interactions between sleep and circadian rhythms; behavioral interventions for sleep; and the impact of sleep on health.
Dr. Buysse has received research funding from the National Institute of Mental Health (NIMH), the National Institute on Aging (NIA), the National Heart, Lung, and Blood Institute (NHLBI), and the National Center for Advancing Translational Science (NCATS). He is Principal Investigator or Co-Investigator on 19 active federally-funded research projects (NIH, PCORI), and over 50 previously-funded research project grants. has He has chaired and served on multiple study sections and advisory committees at the National Institutes of Health (NIH).
Dr. Buysse has published over 400 peer-reviewed articles and over 100 book chapters or review articles. He is Past President of the American Academy of Sleep Medicine, and is currently the president of the Sleep Research Society Board of Directors. Dr. Buysse is a recipient of the Nathaniel Kleitman Distinguished Service Award from the American Academy of Sleep Medicine, the Mary A. Carskadon Outstanding Educator Award from the Sleep Research Society, and the Peter Hauri Career Distinguished Achievement Award from the Society of Behavioral Medicine.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, an
Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish
by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.
In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Joe Feldman is the founder and president of non-profit Cover My Mental Health. Feldman’s involvement in advocacy emerged out of his family’s experience with their health insurance company denying necessary care for one of their kids. After receiving notice that the care was “not medically necessary,” Feldman took steps to hold his insur
Joe Feldman is the founder and president of non-profit Cover My Mental Health. Feldman’s involvement in advocacy emerged out of his family’s experience with their health insurance company denying necessary care for one of their kids. After receiving notice that the care was “not medically necessary,” Feldman took steps to hold his insurer accountable while paying for the care out of savings. Three years later, his family won a federal lawsuit, ultimately collecting from the insurer what should have been paid all along.
His advocacy for mental healthcare access has included a previous board role with Kennedy Forum Illinois and current appointment as a consumer representative to the National Association of Insurance Commissioners. Feldman was the lead author of a 2021 article in the Journal of Psychiatric Practice on medical necessity letters, co-author of a May 2026 article in Capital Psychiatry and a fall 2026 (timing will be known by November) article in the Illinois Bar Journal.
Feldman has made presentations across the country to clinicians, advocacy groups, parents, and community groups towards improving access to mental health and substance use disorder care. Feldman has presented the resources at conferences and Grand Rounds hosted by Group for the Advancement of Psychiatry, National Network of Depression Centers, Menninger Clinic, Lindner Center of Hope, University of Cincinnati, Norton Healthcare, Saint Louis University, Psychotherapy Caucus of APA, American Psychoanalytic Association, National Council for Mental Wellbeing, among others.

Robert G. Sise, MD is a psychiatrist and addiction medicine specialist and the co-founder and CEO of 406 Recovery. His work focuses on expanding access to evidence-based psychiatric and substance use disorder treatment across Montana, with an emphasis on meeting patients where they are in their readiness for change. He previously co-found
Robert G. Sise, MD is a psychiatrist and addiction medicine specialist and the co-founder and CEO of 406 Recovery. His work focuses on expanding access to evidence-based psychiatric and substance use disorder treatment across Montana, with an emphasis on meeting patients where they are in their readiness for change. He previously co-founded and served as Chief Medical Officer of the largest psychiatric practice in the greater Montana region, improving access to outpatient and crisis psychiatric services. He also served as Chief Executive Officer of a joint venture with the Montana Hospital Association, delivering emergency psychiatry consultation services to hospitals across the state.
Dr. Sise began his work in Montana at Billings Clinic, where he founded the organization’s first addiction treatment clinic. He went on to serve as Medical Director of Montana’s first EmPATH Unit, led the consult-liaison psychiatry service, and developed a virtual urgent care program. He completed his MD at the University of California, San Francisco, and holds an MBA and MPH from the University of California, Berkeley, He completed his psychiatry residency and addiction psychiatry fellowship at the University of Washington, where he also served as Chief Resident.
Dr. Sise has lectured at state and regional conferences on the screening, diagnosis, and treatment of substance use disorders. He serves as President of the Northwest Society of Addiction Medicine, representing Montana, North Dakota, and Wyoming. He is board certified in addiction psychiatry, general psychiatry, addiction medicine, and obesity medicine.